Resources

The landscape of medical device development is shifting from the traditional laboratory bench to the high-performance computing cluster. Computational Modeling and Simulation (CM&S)—often referred to as in silico methods —is no longer a futuristic concept but a well-established and increasing presence in regulatory submissions. As these digital twins become more central to demonstrating device safety and effectiveness, the fundamental question for regulators and manufacturers